GA
ELV icon

Glenhill Advisors’s Elevance Health ELV Stock Holding History

Glenhill Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-121,224
Closed -$22.8M – 45
2017
Q2 		$22.8M Sell
121,224
-234,022
-66% -$42M 1.44% 24
2017
Q1 		$58.8M Buy
355,246
+67,303
+23% +$10.7M 4.55% 5
2016
Q4 		$41.4M Buy
+287,943
New +$38.6M 2.93% 14

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Glenhill Advisors's ELV Position: Q3 2017 in Review

Glenhill Advisors sold out of Elevance Health (ELV) in Q3 2017, closing a stake of 121,224 shares — an estimated $22.8M sold.

Glenhill Advisors first reported a position in ELV in Q4 2016 and held it in 3 quarters. The position peaked at $58.8M in Q1 2017. 844 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • Glenhill Advisors reported no remaining Elevance Health position as of Q3 2017 after selling out during the quarter.
  • Glenhill Advisors sold 121,224 Elevance Health shares in Q3 2017, an estimated $22.8M.
  • Glenhill Advisors first reported a position in Elevance Health in Q4 2016 and held it in 3 quarters.
  • Glenhill Advisors's Elevance Health position peaked at $58.8M in Q1 2017.
  • 844 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on Glenhill Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.